Clinical trial designs and study designs

Most errors and technical failures in clinical trials arise due to the improper selection of clinical trial designs. The clinical trial design selection will have a strong impact on the cost and time associated with clinical trials. The expected outcomes shall be thought out and carefully addressed while designing a clinical trial. The selection of […]

Read More →

Myanmar’s pharmaceutical market size was $456 million in 2017, with a percapita pharma expenditure of $8.5 and market researchers expect to reach $656 million in 2022. Myanmar’s economy is growing continuously, and the experts predict the pharmaceutical industry to quickly grow into a $1.12 billion industry in the future. Myanmar depends on the import of […]

Read More →
Generic drug market in Vietnam

The Vietnam generic drug market is growing rapidly with increasing interest in many overseas manufacturers to register their drugs. Vietnam’s pharmaceutical market, along with generic drugs, has grown significantly in the last two years by 10% to US$5.2 billion and is estimated to reach US$6.6 billion this year. This expanding market growth contributes to the […]

Read More →
Import of IMPs into China for clinical trials

Sourcing or importing the IMPs and their supportive products is a challenging process for many researchers and this is more prominent with the countries like China and Japan where understanding the regulations is difficult due to the language barriers and rapid changing norms for making imports.  Many key players in logistics are unclear about the […]

Read More →
Import of IMPs into Japan for clinical trials

Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with multi-regional clinical trials. To import and have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Note: This article […]

Read More →

As clinical trials have become increasingly global and complex, ancillaries have grown in volume, type, and expectations. The clinical trials supply market is projected to reach  USD 2.5 billion by 2025 owing to the logistics services with the increasing number of clinical trials involving temperature-sensitive drugs. Currently, North America is the largest market for clinical […]

Read More →
Import of clinical ancillary supply into Japan for clinical trials

The conduct of clinical trials is a critical process. Along with resource hiring, it also requires materials for different activities. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products necessary for the conduct of clinical trials. It becomes critical to plan for procurement or import of […]

Read More →
Clinical trials in rare disease

The number of clinical trials in rare diseases is growing drastically from the last ten years to more than 500 compared to a few hundred clinical trials. Currently, more than 400 orphan designated drugs are commercially available, and around 1000 drugs are undergoing clinical trials. But still, the clinical trials in rare diseases present many […]

Read More →